ERBB2 and neoplasm: There was no significant difference between the TRG groups in terms of age, gender, comorbidity, Lauren classification, tumor localization, tumor grade, NACT regimen, the numbers of NACT cycles, surgical margin, the numbers of lymph nodes removed, HER-2 status, and ACT regimen.